Category: Press Release - Page 62 - Psychedelic Alpha

Read more about the article Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Post published:June 21, 2022
Post category:Press Release

Read more about the article Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics

Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics

Post published:June 20, 2022
Post category:Press Release

Read more about the article Stephen Bardin to Join atai Life Sciences as CFO Designate

Stephen Bardin to Join atai Life Sciences as CFO Designate

Post published:June 17, 2022
Post category:Press Release

Read more about the article Bexson Biomedical to present at the H.C. Wainwright and Beryl Elites Conferences

Bexson Biomedical to present at the H.C. Wainwright and Beryl Elites Conferences

Post published:June 17, 2022
Post category:Press Release

Read more about the article U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

Post published:June 17, 2022
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

FILAMENT HEALTH ANNOUNCES PATIENT DOSING THROUGH HEALTH CANADA SPECIAL ACCESS PROGRAM

Post published:June 16, 2022
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date

Post published:June 14, 2022
Post category:Press Release

Read more about the article Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Post published:June 9, 2022
Post category:Press Release

Read more about the article Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Post published:June 8, 2022
Post category:Press Release

Read more about the article Enveric Biosciences to Participate in Upcoming Conferences in June 2022

Enveric Biosciences to Participate in Upcoming Conferences in June 2022

Post published:June 8, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.